NCT04145284View on ClinicalTrials.gov

Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Multiple Sclerosis
Trial Locations (2)

44195

Research Site, Cleveland

01307

Research Site, Dresden

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT04145284 - Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS | Biotech Hunter | Biotech Hunter